Global Insights Local Impact
Habil Khorakiwala, founder and chairman, Wockhardt Synopsis Wockhardt’s Habil Khorakiwala has seen the most harrowing days. From a payment default to bond holders to troubled factories, Khorakiwala pulled the company out of its biggest crises. Now, just one drug, that is touted as the biggest breakthrough in antibiotics after penicillin, can bring him back in
Read More
India, home to the world’s largest low- and middle-income (LMIC) population, is now facing a weighty challenge — literally. It accounts for a staggering 15% of the global obesity burden, and by 2040, almost half of the Indian population is projected to be overweight or obese. The latest National Family Health Survey (NFHS-5) reveals a
Read More
“It is a small emergency,” says Amit Bakshi, chairman of Ahmedabad-based drugmaker Eris Lifesciences. He points to the recent decision of Novo Nordisk, the world’s top seller of insulin, to gradually phase out a popular product from India and several other markets as a part of global strategy. Weeks ago, Abbott Labs, the marketing partner
Read More
It is important for state-run health insurance to ensure more hospitals join to provide a safety net to the poor.
Read More
Genetic structure could hold some answers to the vexed issue of cancer. A reference set of genetic variants, specific to India’s diverse ethnic groups, can improve disease modelling and treatment.
Read More
Getty Images Guillain-Barre syndrome (GBS) test, a rare disorder where the body’s immune system damages nerve Synopsis Guillain-Barré Syndrome is a rare nerve disorder. It is not a communicable disease. Why is it spreading like a viral outbreak? After a raft of viruses that sent waves of fear in the last few years, Guillain-Barré Syndrome
Read More
Cyril Konto, CEO, Ichnos Glenmark Innovation and Glenn Saldhana, CMD, Glenmark Pharma; image credit: Glenmark. Synopsis The drug has given promising results for the treatment of multiple myeloma, a rare form of blood cancer. The market for such drugs is expected to touch USD30 billion by the end of the decade. Although these are early
Read More
Umang Vohra, Global CEO, Cipla. Will Cipla’s big bet work?; image credit: Company. Synopsis Millions of diabetes patients have to take a painful insulin injection to keep sugar levels in control. Cipla is introducing Afrezza, an inhaled insulin, in India. Will doctors and patients buy this option? A blue travel case of insulin injections is
Read More
Private equity investors have been investing large sums of money in hospitals. Certain types of hospital chains are delivering healthy returns for such investors.
Read More
Navjot Singh Sidhu with wife Navjot Kaur Sidhu Synopsis Navjot Singh Sidhu claimed his wife’s advanced-stage cancer was cured through alternative remedies, sparking controversy. His suggestion that fasting could kill cancer cells drew criticism. To address this, ET Prime spoke to experts who warned against such misconceptions. Navjot Singh Sidhu has a knack for fuelling
Read More
Doctors are grappling with a raft of unsparing hospital-acquired superbugs broadly known as anti-microbial resistance or AMR. Are bacterial infections the next big lethal adversary for mankind?
Read More
Collage by Manali Ghosh Synopsis 23andMe, a pioneer in genetic testing, struggles to maintain its early success. As quickly as it soared, its market value plummeted, leaving the company’s future uncertain. ET Prime examines the challenges faced by 23andMe, along with opportunities and potential implications for India’s genetic-testing market. Unravelling precise family history and ancestry
Read More
Is the pharma market, which is currently at INR2.17 lakh crore (USD25.8 billion), getting too crowded? While some industry experts believe a few clear signs of fatigue have emerged, many say it is not a doom scenario yet and a rebound may not be far.
Read More
Synopsis Most Indians are sleep-deprived and are turning to melatonin for a better night’s rest. The global melatonin market reached USD2.15 billion in 2022, and India’s sleep aid market is projected to generate USD289 million in revenue in 2024 alone. While melatonin is often considered harmless, everything has a flipside. We all know about ‘city
Read More
Synopsis Last year, Sun Pharma infused over INR4,688 crore to buy US-based Concert Pharma. That deal gave it rights to a drug that helps hair growth in patients suffering from alopecia areata. Leqselvi, the drug, now has the US FDA approval. But there is a new twist in the tale. July 25 marked an important
Read More
Kolkata woman PGT doctor rape-murder: Junior doctors hold protest in state-run hospitals Synopsis The tragic case in Kolkata’s RG Kar Medical College once again exposed the deep flaws in India’s healthcare system. While there are established guidelines and mechanisms to guarantee safety to the medical staff, the ground reality is often different. In a shocking
Read More
Mpox is the latest scare word ripping through the world. The pressing questions are: Is a deadly pandemic like Covid-19 already here? Do we have an effective vaccine ready in case the situation takes a serious turn? Given that mpox virus has made three surges in as many years, it seems to have turned more
Read More
Infertility, once shrouded in cultural taboos and superstition, has emerged as a critical health issue worldwide. In India, the narrative is no different. Let’s reflect on Bimla’s story. She struggled with chronic anxiety due to her in-laws’ continuous pressure to bear a son, despite her “infertility” following the birth of her daughter. Bimla sought help
Read More
Chaitanya Sarawate, president and CEO of GE HealthCare South Asia and managing director of Wipro GE Healthcare; image credit: company. Synopsis GE HealthCare is riding high on the India opportunity. Speaking exclusively to ET Prime, Chaitanya Sarawate, president and CEO of GE HealthCare South Asia and managing director of Wipro GE Healthcare, discusses why the
Read More
In the crosshairs of the latest controversy on whether a drug is spurious or “not of standard quality” is the Indian patient. The pharma industry suffered a body blow recently after government agencies pulled up over 50 popular medicine brands. How do patients trust their medicines?
Read More
Visualisation by Sadhana Saxena via Ai Synopsis A recent animal study has proven green jackfruit flour’s potency in treating fatty liver and liver cancer. An expert group of doctors, scientists, and researchers are coming together to initiate an elaborate clinical trial on this. For Dr. Vinod Abhichandani, it wasn’t any different from the rest of
Read More
Ranjan Pai is among India’s most influential investors. So, when he makes a move into senior care, it is time to sit up and take notice of the sector, not to mention the broader grey economy.
Read More
Dilip Shanghvi , founder, chairman and managing director, Sun Pharmaceutical Industries Limited. Synopsis Selling weight-loss drugs is an opportunity no pharma company wants to miss. Now a leading drug maker from India joins this bandwagon. Trust Sun Pharma boss Dilip Shanghvi to be at the cutting-edge of research. After building a band of specialty drugs
Read More
Sarah McMullen, USFDA India director Synopsis In the past, many within the Indian pharma industry looked at US FDA audits as motivated and a larger conspiracy against it. But this senior official, who heads the Indian operations of the US FDA, and will soon move to China, worked with Indian pharma companies to slowly change
Read More
Image credit: Compiled by Manali Ghosh via AI Synopsis Advent controlled-BSV has charted an exceptional turnaround over the last five years, seeing a 3x jump in its valuation. Its specialised products in women’s health and a robust research pipeline makes it a cynosure of all eyes. As the bidding race to buy BSV intensifies, ET
Read More
Sudhir Srivastava (centre) with his expanding team at SS Innovations; image credit: SS Innovations Synopsis In an exclusive interaction with ET Prime, cardiac surgeon Sudhir Prem Srivastava, the man behind 1,500 successful robotic surgeries, discusses his eventful journey. He details the concept, design and instrumentation of five-armed Mantra, the robotic surgery system, and the dire
Read More
Japanese researchers are soon embarking on human clinical trials for a medicine that will help regrow teeth.
Read More
Shares of Sun Pharmaceuticals, India’s largest drug manufacturer, gained more than 50% over the last one year. In its latest results, the company also posted a 34% on year jump in Q4 profit. While the stock did decline slightly this week, pharma analysts are positive on the stock as the company has shown growth across
Read More
Credit: illustration by Sadhana Saxena via Ai Synopsis Something as cool as a J-Labs can be a welcome step. From fear of failing, scientists can look at the opportunities of scaling. On its part, the government had proposed an innovation-linked fund for new research ideas. But that may have a limited impact. For Andew Martinko,
Read More
As per a recent report in The Lancet, the incidence of prostate cancer is expected to double in India over the next few years. A crucial weapon in averting a severe health catastrophe will be early detection. But before addressing the issue of testing, there’s a knotty ribbon problem to be solved.
Read More
Rakesh Singh took on the tincture syndicate in Agra during his tenure as excise inspector between 2019-23; image credit: N Sundaresha Subramanian Synopsis A well-oiled syndicate of producers, wholesalers and retailers operating across several districts in UP, Bihar and other northern states had exploited a loophole in the 80-year-old law to sell cardamom-laced tinctures as
Read More
Offer Exclusively For You Save up to Rs. 700/- ON ET PRIME MEMBERSHIP Avail Offer Offer Exclusively For You Get 1 Year Free With 1 and 2-Year ET prime membership Avail Offer Offer Exclusively For You Get 1 Year Free With 1 and 2-Year ET prime membership Avail Offer Offer Exclusively For You Get Flat
Read More
Illustration by Sadhana Saxena via AI. Synopsis Advent, which merged Suven Pharma with Cohance Lifesciences in February, looks to take advantage of the China+1 wave and other geopolitical tailwinds. While the skills of its scientists give India an edge in pharma outsourcing, the scale of local contract manufacturers pales in front of global rivals from
Read More
Synopsis With an alarming rise in cancer diagnosis rate in India, especially among the younger cohort, timely screening and therapeutic intervention are the need of the hour. One small state has devised a unique health model for cancer management and success. Here’s how it can help ensure an improved disease-free survival. Cancer, as a lifestyle
Read More
An overlooked mental health challenge faced by new mothers. A powerful new drug could be critical in fighting back. It should have been an obvious match. Yet things may not turn out that way because of pharma industry’s pricing vagaries as well as the lack of conversation around the condition itself.
Read More
Getty Images Synopsis The new government notice tries to prevent the pharmaceutical companies from inducing doctors to prescribe their medicines through vacations, gifts, and free educational material. It is unlikely to succeed. No free gifts. No free Thailand (or Maldives) trips. No “free lunches” at expensive restaurants. In short, that is the clear message from
Read More
Ranjit Shahani, former chief of Novartis Synopsis Ranjit Shahani will be remembered for his astute leadership and trademark calmness amid chaos. As chief of Novartis in India for nearly two decades, his tenure coincided with unprecedented challenges. Shahani had the tedious task of defending his company from a vexing patent battle while convincing the leadership
Read More
Officials from enforcement agencies with the accused charged with making and supplying spurious drugs; image credit: Telangana Drug Control Administration Synopsis In a rare breakthrough, the Telangana drug administration has unearthed a well-oiled network of spurious drug peddlers with operations spanning from the northern state of India to the narrow alleys of Hyderabad. According to
Read More
Chris Boerner, Global CEO, Bristol Myers Squibb; image credit: BMS Synopsis “We are building to be one of the fastest-growing companies by the end of the decade,” says Chris Boerner, CEO, Bristol Myers Squibb. In an exclusive interaction with ET Prime, Boerner discusses the company’s focus on AI, why it is an exciting time to
Read More
As long-haul infections continue to surge, and climate change pushes ticks into new habitats, finding out the causes of these conditions and coming up with cures will become ever more essential.
Read More
Getty Images Synopsis Orchid Pharma had outlicensed its experimental antibiotic drug to Allecra Therapeutics of Germany. After years of research that drug has won crucial approvals from the US FDA and European drug regulatory agency. This marks an important milestone. The drug, invented by Indian scientists in 2008, takes a big leap in the global
Read More
The ImmunoACT team that worked on India’s first approved CAR-T therapy NexCAR 19; image courtesy: ImmunoACT Synopsis NexCAR 19, India’s first cell therapy to treat a specific form of blood cancer, is showing encouraging results. Now listed at 40 hospitals across the country, its indigenous maker, ImmunoACT, is driving a medical revolution. Can the battle
Read More
Rajeev Juneja, vice-chairman and managing director, Mankind Pharma; image credit: Company Synopsis While Ramesh Juneja has led Mankind Pharma for three decades, his brother Rajeev kept in tow and took charge of key operations. Suave and yet rustic, the younger Juneja has a unique style to push the 12,000-strong team of medical representatives in a
Read More
Illustration by Sadhana Saxena via AI Synopsis The recent successes of leading pharmaceutical products show that drug companies have been plain lucky to hit the jackpot. While long-term strategies continue to be important, drug makers have often struck gold with pipeline compounds that they had once simply dumped. Does serendipity help pharmaceutical companies rake in
Read More
Maziar Mike Doustdar, executive VP, Novo Nordisk; image credit: Company Synopsis Novo Nordisk, the most valuable pharmaceutical company in the world, turned 100 last year. While it is largely known for its insulins, its anti-obesity drugs are making waves of late. Maziar Mike Doustdar, executive vice-president, international operations at Novo Nordisk tells ET Prime the
Read More
India’s smaller cities and hinterland remain a neglected lot even as five-star specialty hospitals flourish in the metros. To have its healthcare parameters on track, India needs an urgent flow of investments in tertiary-care hospitals in tier-II and tier-III cities. But building and managing tertiary-care hospitals isn’t easy. Examples like Ujala Cygnus can show the
Read More
Last week, Global Health Ltd, the company which operates hospitals under the brand Medanta, made a strong debut on the Indian stock exchanges. Its shares gained 19% on the listing day. At Thursday’s close of INR462.50 per share, the stock is around 38% up from its issue price of INR336. The company’s initial public offering
Read More
A sharp surge in the number of diabetes patients, 77 million and counting, has turned India into a hotspot for deals to buy or sell prestigious medicine brands to treat the chronic disease. In the latest move, the USD60 billion drug giant Merck, known as MSD in India, has decided to put its iconic anti-diabetes
Read More
Epidemic control workers wear PPE as they wait to remove medical waste from apartments where people who have tested positive are doing home quarantine on December 6, 2022 in Beijing, China. Synopsis In many ways, China has become a victim of its own success. Tough countermeasures helped it cope with the early waves of the
Read More
Nandini Piramal, chairperson, Piramal Pharma; image courtesy of Piramal Pharma. Synopsis Piramal Pharma’s management is optimistic that with revenue growth and margin expansion, it will be able to trim debt over the next five years. But the capital-intensive nature of its main contract manufacturing business scaling remains a challenge. Will Piramal Pharma be able to
Read More
An Indian nurse (L) collects a blood sample from a policeman using a glucometer at a free diabetic health check-up camp on World Health Day in Hyderabad on April 7, 2016. Synopsis India nurses the second highest number of diabetics in the world. For most diabetics, fighting the slow-killer disease involves sticking to pills for
Read More
His name splits the Indian drug industry down the middle. Dinesh Thakur is either admired for his tireless zeal to bring about reform in India’s drug-regulatory system, or tempers flare up at the mention of his name. His motives are often questioned for chasing an “agenda” to malign drugmakers of India, which prides itself on
Read More
Glenn Saldanha, managing director and CEO, Glenmark pharmaceuticals; image credit: Agencies Synopsis Coping with a tough US generics business and high R&D spends, Glenmark’s earnings growth has been muted. To realign with the changing business environment, the company has set new goals for the next four-five years, which includes doubling down on India, its stronghold.
Read More
Canadian physician William Osler is said to have once remarked that medicine is a science of uncertainty and an art of probability. The quote by Osler, known as the father of modern medicine, has of late been recalled during discussions among doctors in light of a study associated with two widely prescribed drugs used to
Read More
Sun Pharmaceutical Industries is scaling new heights. After a setback in the US generic-drugs business, India’s largest drugmaker has gradually moved up the value chain and built a sizeable specialty-drugs business over the last few years. Dilip Shanghvi, founder and managing director of Sun Pharma, with his astute sense of business and passion for science,
Read More
Dr. Rajendra Achyut Badwe, Director, Tata Memorial Center. Synopsis Badwe, director of Mumbai’s Tata Memorial Centre, has reset the rules to revolutionise treatment standards. His views on disease management and research protocols count not just in India but also at world’s leading institutions. Last September, in one such instance, Badwe and his team of doctors
Read More
The convenience of ordering medicines online has attracted millions, especially the elderly. While it may have made life easier for patients, questions have cropped up, leading up to a clash between corporate titans that run online pharmacies and an influential trade body of chemists. The gloves are off, as the likes of Reliance, Tata, Flipkart,
Read More
Technicians fly a drone to deliver medical supplies during testing at Gauribidanur, near Banglore. Synopsis The use of drones in healthcare is in its test phase. There are already instances of medical drones transporting live organs for transplant, delivering vaccines in remote areas, or carrying oxygen cylinders. However, for medical drones to become mainstream, technical,
Read More
“I feel exhausted all the time.” Cheryl (name changed on the condition of anonymity), a 30-year-old artist from New Delhi, was suffering from heavy menstrual bleeding, hot flashes, and chronic fatigue. All of that prompted her to consult a gynaecologist in 2016. The diagnosis came soon enough. Cheryl had polycystic ovary syndrome (PCOS). She would
Read More
Workers unload cartons of a Covid-19 coronavirus vaccine being delivered from India to Myanmar Synopsis The pandemic has catapulted India to the high table of global health diplomacy. Using its position as the world’s leading supplier of vaccines and medicines, it has wielded its soft power to great effect, grabbing significant political clout internationally. In
Read More
Shyam Bishen, chief of health and healthcare division, World Economic Forum; image credit: Twitter Synopsis The scars from the pandemic will take time to heal. Shyam Bishen, chief of health and healthcare division at the World Economic Forum (WEF), elaborates on how to achieve ‘zero health gaps’, the newly formed Global Health Equity Network, and
Read More
Synopsis At a conference last year, India’s new drug controller general Rajeev Raghuvanshi, who was then the scientific director at the Indian Pharmacopeia Commission, cited examples of drugs found to be less effective than desired. Having worked in the industry, he knows its shortcomings. But amid pressure from lobbyists and state agencies that follow different
Read More
For most diabetics, an age-old challenge has been the inability to lose weight despite workouts. For millions of others, tweaking their diet to get slimmer hasn’t produced much of a result. Now, a new class of weight-loss drugs that control glucose levels while cutting cravings is raising hope for folks facing these twin dilemmas. Wegovy
Read More
Rajeev Singh Raghuvanshi, the Drug Controller General of India; image credit: Vikas Dandekar Synopsis The pharmaceutical industry, and the central drug regulatory agency, faced a severe reputation crisis following the deaths of 70 children in Gambia due to contaminated cough syrups in 2022. A few months later, Rajeev Raghuvanshi took over as the Drug Controller
Read More
Dheeraj Jain, founder and MD, Redcliffe Labs; image credit: Redcliffe Labs Synopsis Having set itself a target to reach INR5,000 crore in revenue by 2029, Redcliffe Labs is expanding rapidly and spending big on marketing. But scaling up in a services industry like diagnostics isn’t easy. Without sufficient funding, it may not be able to
Read More
Regulatory lapses have been hurting the industry since long. In several instances earlier, such issues had eroded the financials of top-tier companies. Of late, many companies have again come under the USFDA’s lens. Why has one of the world’s leading suppliers of medicines not learnt from its past, and how can it get its act
Read More
Rajeev Juneja, Vice Chairman & Managing Director at Mankind Pharma Ltd. image courtesy: company. Synopsis Adopting a contrarian strategy, Mankind Pharma chose to tap into small-town markets — an approach that paid rich dividends. Having established a solid base there, and robust financials, it has been increasing its focus on tier-I cities and metros in
Read More
Dilip Jose, Managing Director and CEO at Manipal Hospitals Synopsis Of late, Manipal Health has been focusing on getting bigger and improving operational efficiencies. With an aggressive and execution-oriented management and backing of marquee investors, it has expanded rapidly via the acquisitions route. However, with key rival Apollo Hospitals also increasing bed count across regions,
Read More
Synopsis Ronapreve came as a boon at the peak of the Delta wave in 2021. But as the injection turned ineffective against the Omicron variants, stocks piled up. While Novacare, the distributor, says Max defaulted on dues, the hospital group alleges misrepresentation in the matter. However, the dispute highlights larger issues regarding risks related to
Read More
Concept by Vikas Dandekar and Muhabit ul haq. Synopsis The World Health Organization has lifted the emergency status of the pandemic. With most of the world dropping guard against the virus, it was a symbolic decision. But, as WHO indicated, experts have cautioned that the threat remains. Therefore, the muted phase of the virus should
Read More
Getty Images Synopsis Discussing sexual disorders is no longer a taboo. Young Indians are leading the way to bring out the most secretive healthcare issues around sexual and reproductive health. Startups like Allo, that specialise in providing full-stack solutions for sexual disorders, are helping them. The response has been stupendous with queries trickling in from
Read More
A bird flies past the logo of Sun Pharma installed on the facade of its corporate office in Mumbai, India. Synopsis Dilip Shanghvi’s Sun Pharma made a bold move entering the specialty-drugs business which has started to pay it back. Now, the company is scouting acquisitions and augmenting its in-house R&D to enhance its specialty-drugs
Read More
Synopsis Phages — microscopic viruses that infect bacteria — were discovered over a 100 years ago, and a small band of scientists quickly realised their potential. However, within a few decades of discovery, they were largely abandoned in favour of antibiotics. But as antibiotics increasingly fail us, and the threat of antimicrobial resistance looms large,
Read More
Synopsis A recent study found that 101 million Indians are living with diabetes. From 70 million just four years ago, that’s a jump of over 40%. What’s worse, another 136 million are on the brink of getting the disease. The economic impact of managing a chronically sick population can seriously hobble India’s demographic edge as
Read More
Healthtech company PharmEasy seems to finally be able to hold its head above water. The unicorn, which has been struggling with slowing growth, debt burden, and steep valuation cuts by investors, had something to cheer about when it turned Ebitda (earnings before interest, taxes, depreciation and amortisation) profitable in April this year. For venture capital
Read More
Himanshu Gadgil, CEO, Enzene Biosciences; Enzene Biosciences in Pune; image credit: Enzene Synopsis Anti-cancer drugs are beyond the reach of average Indian patients. Early-stage patients spend up to INR6 lakh on medicines alone. For advanced stages, the cost is higher. Scientist Himanshu Gadgil gave up a cushy job in the US and returned to India
Read More
Lars Fruergaard Jorgensen, global CEO, Novo Nordisk; image credit: Company Synopsis Lars Fruergaard Jørgensen, the CEO of Novo Nordisk, the world’s largest producer of insulins, shares his thoughts on how to arrest the growing numbers of diabetes patients; the company’s blockbuster weight-loss drug Wegovy; regulating medicine prices; and more. For Lars Fruergaard Jørgensen, CEO, Novo
Read More
By Jessica Hamzelou The baby baboon is wearing a mesh gown and appears to be sitting upright. “This little lady … looks pretty philosophical, I would say,” says Eli Katz, who is showing me the image over a Zoom call. This baboon is the first to receive a heart transplant from a young gene-edited pig
Read More
Nikhil Chopra, CEO, JB Chemicals and Pharmaceuticals Ltd. Image credit: Special Arrangement Synopsis When PE firm KKR took control of JB Pharma in 2020, it was struggling for growth. Competitors had cornered the four legacy brands on which the company relied. Then, Nikhil Chopra, a seasoned hand from Cipla, took over. JB Pharma’s subsequent turnaround
Read More
Friends, I represent the Third World. I represent the needs and aspirations of the Third World. I represent the capabilities of the Third World. And above all, I represent an opportunity…. We all have a responsibility to alleviate the suffering of millions of our fellowmen who are afflicted with HIV and AIDS…. Yusuf Hamied, chairman,
Read More
YK Hamied, non-executive chairman, Cipla Synopsis Cipla may be privately owned, but effectively it has been a ‘national asset’ — with each brick representing Indian ingenuity, enterprise, and strength of character. While shareholders will most likely have no reason to complain, the end losers of Cipla’s founding family’s potential exit will be millions of underprivileged
Read More
Apollo Hospital in Mumbai, India. Synopsis Strong financial and operational performance marked the last five years, a consolidation phase for the company. While the robust balance sheet will provide Apollo with a headstart in the next expansion cycle, it is careful not to go overboard while exploring inorganic-growth options. Besides, its digital platform, Apollo 24/7,
Read More
Doctors have earned a place of reverence and high esteem in Indian society. They have been known to selflessly care for patients, a trait that was in ample display during the pandemic. Some of them even sacrificed their lives in the call of duty. But as happens in every profession, medical practice has its share
Read More
Synopsis If Torrent Pharma were to acquire Cipla, which is 2.5 times its size in sales, it would be a bold move. While the acquisition would catapult Torrent to the top of the heap in the domestic market and make it the second-largest Indian pharma company in terms of revenue, financing the deal and integration
Read More
Contract research and manufacturing company Syngene International has had a fabulous run this year. Its stock price has risen over 40% since January amid robust growth and a positive outlook for the business. Syngene’s market capitalisation has reached INR33,000 crore, surpassing the INR32,600 crore market cap of its parent company Biocon. Since its listing in
Read More
“When I started practice in India about 30 years ago, I would see a person under 30 years or between 30 and 35 years with some heart trouble only once or twice in a year. Now I see them every week.” This statement from India’s renowned heart surgeon Ramakant Panda reveals a disturbing reality of
Read More
Health workers wearing personal protective equipment (PPE) take part in a mock drill to check preparations of Covid-19 facilities at JLNM hospital in downtown Srinagar on April 10, 2023. Synopsis Analysing the factors that led to large-scale disruption during the second wave of the Covid-19 in 2021, a study has zeroed in on the issues
Read More
Yan Chow, global healthcare leader, Automation Anywhere Synopsis The healthcare industry is on the verge of a transformation due to the increasing demands and the challenges it faces. Historically, advances in healthcare technology benefited billing and regulatory entities. Doctors and nurses were often the last to adopt new tools. AI is changing this dynamic, as
Read More
Getty Images Mark Cuban. Synopsis Most of the large Indian pharma companies earn a big chunk of their revenue by supplying drugs to the US market. Shark Tank attraction Cuban’s online pharmacy launched last year, which sources medicines directly from manufacturers, holds the promise of catalysing the US businesses of Indian generic drug makers. US-based
Read More
Cyriac Abby Philips, popular on X as Liverdoc, has waged an unyielding battle against alternative medicines like Ayurveda, Homeopathy, Unani and Siddha. This is a daunting task given the deep cultural belief, is and against the backdrop of the government’s strong support to the Ayurveda industry. Unsurprisingly, the Kerala-based hepatologist has picked cudgels against the
Read More
Prof. Mohanasankar Sivaprakasam with his team of senior scientists; image credit: IIT Madras Synopsis Using indigenous proprietary technology, scientists at the institute are slicing the brain down to one-fifth of a human hair to build a bank of images several times sharper in resolution than sophisticated MRI scans. These images can potentially provide path-breaking insights
Read More
Liver specialist Cyriac Abby Philips says there are no approved medicines for treating NASH or non-alcoholic steatohepatitis. Synopsis November 14 was World Diabetes Day. With over 100 million patients, India is in the grip of a diabetes tsunami. In part two of his interview, liver specialist Cyriac Abby Philips says making holistic treatments available is
Read More
Three months ago, Robert M Califf, commissioner of the US Food and Drug Administration (USFDA) visited India to strengthen efforts on development, supply, and quality of drugs. For the US, where more than nine out of 10 prescriptions dispensed are generic drugs, India is a critical partner, responsible for supplying a substantial portion of these
Read More
Cui Xiaotian, Zhao Jinzhao, Zhou Xinda, Hua Ang, Chengxi, Tan Chen, and Han Wei Liu Ping, a 25-year-old living in Beijing, is queuing up outside the obesity clinic of the Peking University People’s Hospital early one morning, seeking a doctor’s prescription for the so-called “skinny jab” — a weight loss drug that has created a
Read More
Synopsis Improving financials of hospital chains, future growth prospects of the sector itself have attracted investors to hospital stocks. But while Apollo Hospitals and Max Healthcare led the gains post Covid-19, this calendar year Narayana Hrudayalaya has outperformed other major hospital stocks with a 72% rise in its share price. What lies ahead for the
Read More
Getty Images Synopsis The irreversible lung disease is affecting a large part of India’s population, especially the elderly. It is the biggest cause of mortality after heart ailments, while the rising number of cases reported among non-smokers in rural India raises an alarm. Veteran chest surgeon and lung-transplant specialist Arvind Kumar faces a grim reality
Read More